Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» CNS disorders
CNS disorders
JPM2023: Breakthroughs await, but so do roadblocks
JPM2023: Breakthroughs await, but so do roadblocks
Pharmaphorum
JPMHC 2023
Inflation Reduction Act
cell therapy
gene therapy
clinical trials
CNS disorders
Flag link:
Lilly's Prevail, Capsida partner to develop gene therapies for nervous system diseases
Lilly's Prevail, Capsida partner to develop gene therapies for nervous system diseases
BioPharma Dive
Eli Lilly
gene therapy
Capsida
CNS disorders
Prevail Therapeutics
Flag link:
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
MedCity News
Arbor Biotechnologies
MIT
liver disease
CNS disorders
funding
CRISPR
Flag link:
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Pharmaceutical Business Review
Ironwood Pharmaceuticals
IW-6463
CNS disorders
clinical trials
Flag link:
